Gentile I - Search Results

1

Incidence and Predictive Risk Factors of Infective Events in Patients With Multiple Sclerosis Treated With Agents Targeting CD20 and CD52 Surface Antigens.

Zappulo E, Buonomo AR, Saccà F, Russo CV, Scotto R, Scalia G, Nozzolillo A, Lanzillo R, Tosone G, Gentile I. Zappulo E, et al. Among authors: gentile i. Open Forum Infect Dis. 2019 Oct 21;6(11):ofz445. doi: 10.1093/ofid/ofz445. eCollection 2019 Nov. Open Forum Infect Dis. 2019. PMID: 31723572 Free PMC article.

2

A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?

Tosone G, Borgia G, Gentile I, Cerini R, Conte MC, Orlando R, Piazza M. Tosone G, et al. Among authors: gentile i. Acta Diabetol. 2007 Sep;44(3):167-9. doi: 10.1007/s00592-007-0259-1. Epub 2007 Aug 26. Acta Diabetol. 2007. PMID: 17721757

3

Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient.

Gentile I, Bonadies G, Buonomo AR, Minei G, Borrelli F, Foggia M, Chiurazzi F, Borgia G. Gentile I, et al. Platelets. 2013;24(7):574-7. doi: 10.3109/09537104.2012.735721. Epub 2012 Nov 6. Platelets. 2013. PMID: 23130846 Free article.

4

Response to measles-mumps-rubella vaccine in children with autism spectrum disorders.

Gentile I, Bravaccio C, Bonavolta R, Zappulo E, Scarica S, Riccio MP, Settimi A, Portella G, Pascotto A, Borgia G. Gentile I, et al. In Vivo. 2013 May-Jun;27(3):377-82. In Vivo. 2013. PMID: 23606694

5

Etiopathogenesis of autism spectrum disorders: fitting the pieces of the puzzle together.

Gentile I, Zappulo E, Militerni R, Pascotto A, Borgia G, Bravaccio C. Gentile I, et al. Med Hypotheses. 2013 Jul;81(1):26-35. doi: 10.1016/j.mehy.2013.04.002. Epub 2013 Apr 25. Med Hypotheses. 2013. PMID: 23622947

6

Concomitant interferon-alpha and chemotherapy in hepatitis C and colorectal cancer: a case report.

Gentile I, De Stefano A, Di Flumeri G, Buonomo AR, Carlomagno C, Morisco F, De Placido S, Borgia G. Gentile I, et al. In Vivo. 2013 Jul-Aug;27(4):527-9. In Vivo. 2013. PMID: 23812225

7

A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir.

Gentile I, Borgia F, Buonomo AR, Castaldo G, Borgia G. Gentile I, et al. Curr Med Chem. 2013;20(30):3733-42. doi: 10.2174/09298673113209990178. Curr Med Chem. 2013. PMID: 23848533 Review.

8

Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era.

Gentile I, Borgia F, Zappulo E, Buonomo AR, Spera AM, Castaldo G, Borgia G. Gentile I, et al. Rev Recent Clin Trials. 2014;9(1):1-7. doi: 10.2174/1574887108666131213120354. Rev Recent Clin Trials. 2014. PMID: 23859195 Review.

9

A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C.

Gentile I, Coppola N, Pasquale G, Liuzzi R, D'Armiento M, Di Lorenzo ME, Capoluongo N, Buonomo AR, Sagnelli E, Morisco F, Caporaso N, Borgia G. Gentile I, et al. Hepat Mon. 2013 May 8;13(5):e8352. doi: 10.5812/hepatmon.8352. eCollection 2013 May. Hepat Mon. 2013. PMID: 23967022 Free PMC article.

10

In vivo antiviral activity of telbivudine against HIV-1: a case report.

Gentile I, Bonadies G, Carleo MA, Buonomo AR, Borrelli F, Portella G, Borgia G. Gentile I, et al. Infez Med. 2013 Sep;21(3):216-9. Infez Med. 2013. PMID: 24008855 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters